Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP547984.RAiS6Zg1Pz151G0lyj0dCYatuW4xcHcGh91lz12p9MEgI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP547984.RAiS6Zg1Pz151G0lyj0dCYatuW4xcHcGh91lz12p9MEgI130_assertion type Assertion NP547984.RAiS6Zg1Pz151G0lyj0dCYatuW4xcHcGh91lz12p9MEgI130_head.
- NP547984.RAiS6Zg1Pz151G0lyj0dCYatuW4xcHcGh91lz12p9MEgI130_assertion description "[Following confirmation of the natural history of this leukemia in the transgenic mice, we demonstrated that the transformed murine lymphocytes express relevant therapeutic targets (Bcl-2, Mcl-1, AKT, PDK1, and DNMT1), wild-type p53 status, and in vitro sensitivity to therapeutic agents relevant to the treatment of human CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547984.RAiS6Zg1Pz151G0lyj0dCYatuW4xcHcGh91lz12p9MEgI130_provenance.
- NP547984.RAiS6Zg1Pz151G0lyj0dCYatuW4xcHcGh91lz12p9MEgI130_assertion evidence source_evidence_literature NP547984.RAiS6Zg1Pz151G0lyj0dCYatuW4xcHcGh91lz12p9MEgI130_provenance.
- NP547984.RAiS6Zg1Pz151G0lyj0dCYatuW4xcHcGh91lz12p9MEgI130_assertion SIO_000772 16670263 NP547984.RAiS6Zg1Pz151G0lyj0dCYatuW4xcHcGh91lz12p9MEgI130_provenance.
- NP547984.RAiS6Zg1Pz151G0lyj0dCYatuW4xcHcGh91lz12p9MEgI130_assertion wasDerivedFrom befree-2016 NP547984.RAiS6Zg1Pz151G0lyj0dCYatuW4xcHcGh91lz12p9MEgI130_provenance.
- NP547984.RAiS6Zg1Pz151G0lyj0dCYatuW4xcHcGh91lz12p9MEgI130_assertion wasGeneratedBy ECO_0000203 NP547984.RAiS6Zg1Pz151G0lyj0dCYatuW4xcHcGh91lz12p9MEgI130_provenance.